- Home
- ATNM vs CFSB Comparison
ATNM vs CFSB Comparison
Compare ATNM & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- CFSB
- Stock Information
- Founded
- ATNM 2000
- CFSB 1889
- Country
- ATNM United States
- CFSB United States
- Employees
- ATNM N/A
- CFSB N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- CFSB Major Banks
- Sector
- ATNM Health Care
- CFSB Finance
- Exchange
- ATNM Nasdaq
- CFSB Nasdaq
- Market Cap
- ATNM 46.5M
- CFSB 50.1M
- IPO Year
- ATNM N/A
- CFSB N/A
- Fundamental
- Price
- ATNM $1.21
- CFSB $7.94
- Analyst Decision
- ATNM Strong Buy
- CFSB
- Analyst Count
- ATNM 4
- CFSB 0
- Target Price
- ATNM $8.75
- CFSB N/A
- AVG Volume (30 Days)
- ATNM 1.4M
- CFSB 1.4K
- Earning Date
- ATNM 04-29-2025
- CFSB 04-28-2025
- Dividend Yield
- ATNM N/A
- CFSB N/A
- EPS Growth
- ATNM N/A
- CFSB N/A
- EPS
- ATNM N/A
- CFSB N/A
- Revenue
- ATNM N/A
- CFSB $7,462,000.00
- Revenue This Year
- ATNM N/A
- CFSB N/A
- Revenue Next Year
- ATNM N/A
- CFSB N/A
- P/E Ratio
- ATNM N/A
- CFSB N/A
- Revenue Growth
- ATNM N/A
- CFSB N/A
- 52 Week Low
- ATNM $1.03
- CFSB $6.34
- 52 Week High
- ATNM $10.24
- CFSB $8.28
- Technical
- Relative Strength Index (RSI)
- ATNM 43.76
- CFSB 57.75
- Support Level
- ATNM $1.18
- CFSB $7.73
- Resistance Level
- ATNM $1.34
- CFSB $7.98
- Average True Range (ATR)
- ATNM 0.15
- CFSB 0.19
- MACD
- ATNM -0.03
- CFSB 0.03
- Stochastic Oscillator
- ATNM 11.99
- CFSB 94.44
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.